Dr Thakur Gurjeet Singh
Associate Professor and HOD

gurjeet.singh@chitkara.edu.in

Expert Areas :

  • Research
  • Teaching
  • Patents
  • Education

Field of Specialization – Comprehensive knowledge of basic principles of clinical and preclinical drug development, derived from extensive graduate training in Pharmacology. Conducted research focused on the neuroprotective mechanism of Pharmacological preconditioning, Alzheimer, Parkinsonism. As Pharmacological preconditioning plays an important role in neurodegenerative disorders so extensive information, regarding protective role of adenosine, Opioid, CGRP, calcium, protein kinase-C, heat shock proteins and MAP kinase as triggering mechanism in Pharmacological preconditioning, is provided. Research is oriented to find out the noval pathways of Pharmacological preconditioning in neurodegenerative disorders and drug dependence such as brain stroke by using various drugs like Morphine, Capsaicin. Mechanistic studies related with drug dependence like Nicotine, Alcohol and Morphine dependence. Key research expertise areas include: Animal models development and validation. Neurodegenerative disorders (Stroke, Epilepsy, Dementia, Alzheimer & Parkinson), substance dependence Nicotine dependence, Morphine dependence, Alcohol dependence, ALS, Stem cell Therapy, Tradive Dyskinesaia Parkinson,  Preconditioning and anesthetic techniques, histopathological and various behavioral data evaluation.

  • Synergistic Composition for Treatment of Neurological Disorders. Filing Date: 22/07/2015.
  • Synergistic Composition of Scopolamine and Venlafaxine for Treatment of Drug Resistant Depression. Filing Date 29/09/2015.
  • Therapeutic composition for the treatment and prevention of Alzheimer’s disease and other neurodegenerative disorders. Patent Application Filing Date: 29/04/2016, Patent Filing Number: 201611015013.
  • Cutaneous Analgesic Effect of Topically Administered Midazolam. Patent Application Filing Date: 31/05/2016; Patent Filing Number:1/17222/2016-DEL
  • Novel herbal alcoholic extract with dual activity as hypersensitive and blood thinner agent.
  • 2011-2015 : PhD in Faculty of Pharmaceutical Sciences (Pharmacology) from Chitkara University, Punjab (“EXPLORATION AND EVALUATION OF NOVEL PHARMACOLOGICAL APPROACHES FOR ATTENUATION OF NICOTINE DEPENDENCE INDUCED WITHDRAWAL SYNDROME IN MICE”). CGPA: 9.5/10.
  • 2013:  Professional Certificate Programme in Pharmacovigilance (PCPV), Catalyst Clinical Services Pvt. Ltd., Delhi,
  • 2009: Professional Diploma in Clinical Research from Catalyst Clinical Services Pvt. Ltd,   Delhi.
  • 2005-2007:  Master of Pharmacy (Pharmacology), Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India 66.9%, (NEUROPROTECTIVE MECHANISM OF PHARMACOLOGICAL    PRECONDITIONING: AN INTERPLAY BETWEEN OPIOID AND CGRP    RECEPTOR TRANSDUCTION PATHWAY ).
  • 2000-2004:  Bachelor of Pharmacy, Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India.